Developer docs
API playgroundTry for free, no card

Search company profiles

BioRay Biotech

Full company profile

uuid002r9y9

Namestring
BioRay Biotech
Legal namestring
光晟生物科技股份有限公司
Websiteurl
bio-ray.com.tw
Company typeenum
Private
Founded yearint
2000
Descriptiontext

BioRay Biotech (光晟生技 / 光晟生物科技股份有限公司) is a privately-held Taiwanese bio-pharmaceutical company founded in 2005 and headquartered in the Tainan Southern Science Industrial Park (manufacturing operations in Pingtung Agricultural Biotechnology Park). The company operates three intertwined business lines: (1) Precision Medical Testing services spanning Oncology Profile (NGS + LC-MS/MS + PCR), Gut Microbiome analysis, Immune Profile (flow cytometry), and an integrated Health Insights offering; (2) CIK (Cytokine-Induced Killer) immune cell therapy, manufactured at Taiwan FDA GTP-certified facilities (Tainan TP110C026, Kaohsiung TP112C033) and delivered through five named Taiwan hospital partners including Chi Mei Medical Center and Gaohe Hospital, with reported outcomes of 99.9% cell purity, 82% NK-cell activity enhancement in three-year follow-up, and 500+ stage IV solid tumor patients treated; (3) Health supplements, sold both as proprietary consumer brands (Haokang Probiotics / 好康益生菌, Tanganding PLUS, Gulijie, Yilushui, Cordyceps lines) and via ODM/OEM contract manufacturing for 20+ domestic and international brands using its patented micro-pellet formulation technology and patented probiotic strains. Annual raw material exports exceed 5 tons and one partner brand's BR022-based product has surpassed 500,000 boxes in annual sales.

Short descriptiontext

BioRay Biotech is a Taiwanese bio-pharmaceutical company that develops patented probiotic strains, GTP-certified CIK immune cell therapy, and precision medical testing services for hospitals, health-conscious consumers, and health supplement brands preparing for Taiwan OTC listing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPingtung, Taiwan
HQ citystring
Pingtung
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
probiotic strain development, cell therapy services, precision medical testing, health supplement manufacturing, ODM/OEM contract manufacturing
Industry4 codes
PRIMARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYHLAIAAAD
Immunology & Inflammation Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAB
Immunology & Autoimmune Specialty Pharmaceuticals
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code5 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmaceutical Preparation Manufacturing325412
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
  • Medicinal and Botanical Manufacturing325411
SIC code4 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Medical Laboratories8071
  • Medicinal Chemicals & Botanical Products2833
Product category
Bio-pharmaceutical Probiotics and Cell Therapy
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Health Supplement Sales (Own Brands)
TypeSubscription Recurring
Description

Sales of proprietary health supplement products under the BioRay brand, including probiotics, cordyceps, and functional health products through direct sales and retail channels.

bio-ray.com.tw
2ODM/OEM Contract Manufacturing
TypeOne Time License
Description

Custom formulation, manufacturing, and branding services for B2B partners seeking to incorporate BioRay's patented probiotic strains and micro-pellet technologies into their own health supplement brands. Contributes 60% of revenue from own brands and 30% annual growth from B2B raw material exports.

bio-ray.com.tw
3CIK Immune Cell Therapy
TypeProfessional Services
Description

GTP-certified CIK cell preparation and related cell therapy services provided in partnership with hospitals, serving as a cell product supplier for clinical applications under Taiwan FDA regenerative medicine regulations.

bio-ray.com.tw
4Precision Medical Testing Services
TypeSubscription Recurring
Description

Comprehensive health testing services including cancer risk assessment, immune function analysis, gut microbiome and nutritional analysis, and holistic health data insights, offered to individuals and through hospital partnerships.

bio-ray.com.tw
5Patented Raw Material Licensing
TypeLicensing Royalties
Description

Export and licensing of internationally patented probiotic strains and fermentation technologies to international brands, with partnerships including over 20 domestic and international brands and annual export exceeding 5 tons.

bio-ray.com.tw
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales
Pricing details2 tiers
1B2C Health Supplements - Individual consumer products and testing services
ModelSubscriptionBilling cadenceMonthly
Notes

Consumer health supplements and personalized testing services are available for individual purchase with pricing provided upon consultation. Service hotline: 0800-200-026 for health inquiries, 06-505-2755 for testing appointments.

bio-ray.com.tw
2ODM/OEM Manufacturing - Enterprise B2B partnerships
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Custom formulation and contract manufacturing services priced based on product complexity, volume, and specific patented ingredient requirements. Enterprise hotline: 08-762-6868.

bio-ray.com.tw
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1好康益生菌 (Haokang Probiotics)
Description

Nationally certified health food with dual efficacy for allergic constitution adjustment and gastrointestinal function improvement

bio-ray.com.tw
+4 more records
Core offering1 text field

BioRay Biotech researches, develops, manufactures, and distributes bio-pharmaceutical products spanning three integrated business lines: (1) precision medical testing services including cancer risk assessment, immune function analysis, gut microbiome analysis, and holistic health data insights built on six integrated technology platforms; (2) CIK (Cytokine-Induced Killer) immune cell therapy services delivered through GTP-certified facilities and partner hospitals for solid tumor patients; and (3) branded and ODM/OEM health supplement products based on 17 patented probiotic strains, Cordyceps militaris, Antrodia cinnamomea, and patented micro-pellet formulation technology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • Over 500 stage IV solid tumor patients treated with CIK cell therapy
+8 more records
Product overview1 text field

BioRay Biotech offers a unified precision medicine platform combining three core service areas: (1) Precision Medical Testing — including Oncology Profile, Gut Microbiome, Immune Profile, and Health Insights services that integrate six technology platforms (Flow Cytometry, NGS, Microfluidic Chip, LC-MS/MS, Real-Time PCR, Qubit Fluorometer) for comprehensive health assessment; (2) CIK Immune Cell Therapy — GTP-certified cell preparation and treatment services for cancer patients with stage I-IV solid tumors, developed through collaborations with Chi Mei Hospital and Gaohe Hospital; and (3) Health Supplements — ODM/OEM manufacturing services and proprietary branded products featuring patented probiotic strains (BRAP-01, BR-022, BR-0121), Cordyceps militaris with 29x cordycepin content, Antrodia cinnamomea, and patented micro-pellet drug delivery technology. The company operates a Taiwan FDA GTP-certified cell preparation facility and provides testing services to external clients.

Product and service9 records
1Oncology Profile (癌症風險評估)
CategoryPrecision Medical Testing
Description

Precision cancer risk assessment combining Next-Generation Sequencing (NGS), Liquid Chromatography-Mass Spectrometry (LC-MS/MS), and real-time PCR to analyze genes, metabolites, and circulating cell-free DNA for early cancer risk detection in individuals and hospital-referred patients.

2Gut Microbiome Analysis (腸道菌相與營養分析)
CategoryPrecision Medical Testing
Description

Integrated gut microbiota and nutritional metabolism analysis using NGS and LC-MS/MS to assess intestinal barrier integrity and provide personalized dietary and probiotic recommendations for health-conscious individuals and clinical patients.

3Immune Profile (免疫功能分析)
CategoryPrecision Medical Testing
Description

Functional immune analysis focusing on immune cell subpopulation composition and cellular combat power quantification beyond traditional cell count measurements, performed at Taiwan FDA LDTS-certified laboratory (LDT0005).

4Health Insights (全方位健康數據洞察)
CategoryPrecision Medical Testing
Description

Comprehensive health data analysis integrating six technology platforms (Flow Cytometry, NGS, Microfluidic Chip, LC-MS/MS, Real-Time PCR, Qubit Fluorometer) to generate personalized health blueprints with actionable recommendations.

5CIK Immune Cell Therapy (CIK免疫細胞治療)
CategoryCell Therapy Services
Description

Cytokine-Induced Killer (CIK) immune cell therapy for cancer adjunctive treatment, enhancing immune cell killing power through induced proliferation and activation for stage I-IV solid tumor patients. Delivered through partner hospitals including Chi Mei Medical Center and Gaohe Hospital; over 500 stage IV solid tumor patients treated.

6Patented Probiotic Raw Materials and Ingredients (專利原料)
CategoryPatented Raw Materials
Description

Proprietary patented probiotic strains and functional ingredients sold as raw materials to health supplement brands globally. Includes BRAP-01 (82% allergy regulation efficacy), BR-022 (90%+ intestinal relief within 7 days), BR-0121 (metabolic regulation), Cordyceps militaris (29x wild cordycepin), and Antrodia cinnamomea. Annual raw material exports exceed 5 tons to over 20 brands.

7BioRay Product Portfolio (光晟系列產品)
CategoryBranded Health Supplements
Description

Branded health supplement product portfolio targeting children, adults, seniors, and women. Includes Haokang Probiotics (nationally certified health food, 衛署健食字第A00201號), Gulijie (senior bone health), Tanganding PLUS (metabolic regulation built on BR-0121), Yilushui (senior health), and Haoyihuo (premium senior brand using BR022 strain formulation, >500,000 boxes sold annually).

8GTP Cell Preparation Facility Service (GTP等級細胞製備場所)
CategoryCell Manufacturing Services
Description

GTP-certified cell preparation facility providing contract development and manufacturing services for cell therapy products, with capabilities including sterility, mycoplasma, and endotoxin testing under Taiwan FDA recognition (TP110C026 Tainan Plant; TP112C033 Kaohsiung Plant).

9ODM/OEM Health Supplement Manufacturing (專業代工ODM/OEM)
CategoryContract Manufacturing Services
Description

Original design and manufacturing services for health supplements, offering exclusive patented raw materials (BRAP-01, BR-022, BR-0121, Cordyceps, Antrodia), full dosage form production including patented micro-pellet formulations, and packaging design for brand partners.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Swedish global leader in probiotic R&D and B2B ingredient licensing with clinically documented Lactobacillus strains. Comparable as a probiotic IP licensor selling patented strains into supplement and functional food brands worldwide.

TypeBroad incumbent
Description

Global contract development and manufacturing organization (CDMO) for biologics and cell & gene therapies. Comparable as a provider of GMP/GTP-equivalent cell therapy manufacturing services, though at much larger scale.

TypeBroad incumbent
Description

Global probiotic dairy and supplement brand built on proprietary Lactobacillus strain science (Shirota strain). Comparable as a vertically integrated probiotic IP owner with branded consumer products and B2B licensing.

4SunWay Biotech
TypeDirect peer
Description

Taiwan-based biotech active in immune cell therapies (including CIK/DC-CIK) and precision testing. Closely comparable to BioRay's CIK cell therapy and precision testing service lines.

TypeDirect peer
Description

Taiwan-based probiotic and functional ingredient manufacturer with patented Lactobacillus strains and ODM/OEM services. Highly comparable to BioRay's supplement franchise, including strain bank ownership and international B2B raw material exports.

TypeDirect peer
Description

Taiwan nutraceutical/functional food contract manufacturer with ODM/OEM capabilities and proprietary ingredient IP. Comparable as a Taiwanese health-supplement ODM competitor with patented raw materials.

TypeRegional player
Description

Taiwan-listed biopharmaceutical company developing biologic drugs (notably ropeginterferon). Comparable as a Taiwan biotech pursuing international commercialization of a proprietary biologic, though focused on oncology/inflammation rather than probiotics.

8Grape King Bio
TypeDirect peer
Description

Taiwan-listed health supplement and probiotic company combining proprietary fermentation with branded products and OEM services. Closely comparable in business model (probiotics + health foods + ODM) and target customer base.

TypeBroad incumbent
Description

Global bioscience major with one of the world's largest commercial probiotic strain libraries and B2B ingredient supply across food, supplement, and animal health. Comparable as a scale probiotic raw-material and culture supplier competing for the same brand customers.

TypeBroad incumbent
Description

Global taste and nutrition company with a major probiotic and postbiotic ingredient business serving supplement, dairy, and functional food brands. Comparable as a large-scale buyer of probiotic technology and competitor for branded health-supplement customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioRay Biotech

Bio-pharmaceutical Probiotics and Cell Therapybio-ray.com.tw

BioRay Biotech is a Taiwanese bio-pharmaceutical company that develops patented probiotic strains, GTP-certified CIK immune cell therapy, and precision medical testing services for hospitals, health-conscious consumers, and health supplement brands preparing for Taiwan OTC listing.

What BioRay Biotech does

BioRay Biotech (光晟生技 / 光晟生物科技股份有限公司) is a privately-held Taiwanese bio-pharmaceutical company founded in 2005 and headquartered in the Tainan Southern Science Industrial Park (manufacturing operations in Pingtung Agricultural Biotechnology Park). The company operates three intertwined business lines: (1) Precision Medical Testing services spanning Oncology Profile (NGS + LC-MS/MS + PCR), Gut Microbiome analysis, Immune Profile (flow cytometry), and an integrated Health Insights offering; (2) CIK (Cytokine-Induced Killer) immune cell therapy, manufactured at Taiwan FDA GTP-certified facilities (Tainan TP110C026, Kaohsiung TP112C033) and delivered through five named Taiwan hospital partners including Chi Mei Medical Center and Gaohe Hospital, with reported outcomes of 99.9% cell purity, 82% NK-cell activity enhancement in three-year follow-up, and 500+ stage IV solid tumor patients treated; (3) Health supplements, sold both as proprietary consumer brands (Haokang Probiotics / 好康益生菌, Tanganding PLUS, Gulijie, Yilushui, Cordyceps lines) and via ODM/OEM contract manufacturing for 20+ domestic and international brands using its patented micro-pellet formulation technology and patented probiotic strains. Annual raw material exports exceed 5 tons and one partner brand's BR022-based product has surpassed 500,000 boxes in annual sales.

BioRay Biotech firmographics

Firmographics
Name
BioRay Biotech
Legal name
光晟生物科技股份有限公司
Website
https://bio-ray.com.tw
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
BioRay Biotech is a Taiwanese bio-pharmaceutical company that develops patented probiotic strains, GTP-certified CIK immune cell therapy, and precision medical testing services for hospitals, health-conscious consumers, and health supplement brands preparing for Taiwan OTC listing.
Ownership category
akta.pro rank

BioRay Biotech industry classification

Industry
Product category
Bio-pharmaceutical Probiotics and Cell Therapy
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Medicinal and Botanical Manufacturing (325411)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYHLAIAAAD
Immunology & Inflammation Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAB
Immunology & Autoimmune Specialty Pharmaceuticals
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Probiotic strain development
  • Cell therapy services
  • Precision medical testing
  • Health supplement manufacturing
  • ODM/OEM contract manufacturing

Where BioRay Biotech is headquartered

Location

Headquarters

HQ city
Pingtung
HQ country
Taiwan
HQ region
Asia

Offices3 records

Markets served

BioRay Biotech business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Health Supplement Sales (Own Brands): Sales of proprietary health supplement products under the BioRay brand, including probiotics, cordyceps, and functional health products through direct sales and retail channels.
  2. ODM/OEM Contract Manufacturing: Custom formulation, manufacturing, and branding services for B2B partners seeking to incorporate BioRay's patented probiotic strains and micro-pellet technologies into their own health supplement brands. Contributes 60% of revenue from own brands and 30% annual growth from B2B raw material exports.
  3. CIK Immune Cell Therapy: GTP-certified CIK cell preparation and related cell therapy services provided in partnership with hospitals, serving as a cell product supplier for clinical applications under Taiwan FDA regenerative medicine regulations.
  4. Precision Medical Testing Services: Comprehensive health testing services including cancer risk assessment, immune function analysis, gut microbiome and nutritional analysis, and holistic health data insights, offered to individuals and through hospital partnerships.
  5. Patented Raw Material Licensing: Export and licensing of internationally patented probiotic strains and fermentation technologies to international brands, with partnerships including over 20 domestic and international brands and annual export exceeding 5 tons.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyB2C Health Supplements - Individual consumer products and testing services
One time/ perpetual licenseMulti-year contractODM/OEM Manufacturing - Enterprise B2B partnerships

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

BioRay Biotech product offering

Product offering

Core offering

BioRay Biotech researches, develops, manufactures, and distributes bio-pharmaceutical products spanning three integrated business lines: (1) precision medical testing services including cancer risk assessment, immune function analysis, gut microbiome analysis, and holistic health data insights built on six integrated technology platforms; (2) CIK (Cytokine-Induced Killer) immune cell therapy services delivered through GTP-certified facilities and partner hospitals for solid tumor patients; and (3) branded and ODM/OEM health supplement products based on 17 patented probiotic strains, Cordyceps militaris, Antrodia cinnamomea, and patented micro-pellet formulation technology.

Product overview

BioRay Biotech offers a unified precision medicine platform combining three core service areas: (1) Precision Medical Testing — including Oncology Profile, Gut Microbiome, Immune Profile, and Health Insights services that integrate six technology platforms (Flow Cytometry, NGS, Microfluidic Chip, LC-MS/MS, Real-Time PCR, Qubit Fluorometer) for comprehensive health assessment; (2) CIK Immune Cell Therapy — GTP-certified cell preparation and treatment services for cancer patients with stage I-IV solid tumors, developed through collaborations with Chi Mei Hospital and Gaohe Hospital; and (3) Health Supplements — ODM/OEM manufacturing services and proprietary branded products featuring patented probiotic strains (BRAP-01, BR-022, BR-0121), Cordyceps militaris with 29x cordycepin content, Antrodia cinnamomea, and patented micro-pellet drug delivery technology. The company operates a Taiwan FDA GTP-certified cell preparation facility and provides testing services to external clients.

Differentiator

Problem solved

Functional benefit

Brands

  • 好康益生菌 (Haokang Probiotics): Nationally certified health food with dual efficacy for allergic constitution adjustment and gastrointestinal function improvement
  • 古力捷 (Gulijie)
  • 田甘定 PLUS (Tanganding PLUS)
  • 益路水 (Yilushui)
  • 好益活 (Haoyihuo)

Products and services

  • Oncology Profile (癌症風險評估) Precision cancer risk assessment combining Next-Generation Sequencing (NGS), Liquid Chromatography-Mass Spectrometry (LC-MS/MS), and real-time PCR to analyze genes, metabolites, and circulating cell-free DNA for early cancer risk detection in individuals and hospital-referred patients.
  • Gut Microbiome Analysis (腸道菌相與營養分析) Integrated gut microbiota and nutritional metabolism analysis using NGS and LC-MS/MS to assess intestinal barrier integrity and provide personalized dietary and probiotic recommendations for health-conscious individuals and clinical patients.
  • Immune Profile (免疫功能分析) Functional immune analysis focusing on immune cell subpopulation composition and cellular combat power quantification beyond traditional cell count measurements, performed at Taiwan FDA LDTS-certified laboratory (LDT0005).
  • Health Insights (全方位健康數據洞察) Comprehensive health data analysis integrating six technology platforms (Flow Cytometry, NGS, Microfluidic Chip, LC-MS/MS, Real-Time PCR, Qubit Fluorometer) to generate personalized health blueprints with actionable recommendations.
  • CIK Immune Cell Therapy (CIK免疫細胞治療) Cytokine-Induced Killer (CIK) immune cell therapy for cancer adjunctive treatment, enhancing immune cell killing power through induced proliferation and activation for stage I-IV solid tumor patients. Delivered through partner hospitals including Chi Mei Medical Center and Gaohe Hospital; over 500 stage IV solid tumor patients treated.
  • Patented Probiotic Raw Materials and Ingredients (專利原料) Proprietary patented probiotic strains and functional ingredients sold as raw materials to health supplement brands globally. Includes BRAP-01 (82% allergy regulation efficacy), BR-022 (90%+ intestinal relief within 7 days), BR-0121 (metabolic regulation), Cordyceps militaris (29x wild cordycepin), and Antrodia cinnamomea. Annual raw material exports exceed 5 tons to over 20 brands.
  • BioRay Product Portfolio (光晟系列產品) Branded health supplement product portfolio targeting children, adults, seniors, and women. Includes Haokang Probiotics (nationally certified health food, 衛署健食字第A00201號), Gulijie (senior bone health), Tanganding PLUS (metabolic regulation built on BR-0121), Yilushui (senior health), and Haoyihuo (premium senior brand using BR022 strain formulation, >500,000 boxes sold annually).
  • GTP Cell Preparation Facility Service (GTP等級細胞製備場所) GTP-certified cell preparation facility providing contract development and manufacturing services for cell therapy products, with capabilities including sterility, mycoplasma, and endotoxin testing under Taiwan FDA recognition (TP110C026 Tainan Plant; TP112C033 Kaohsiung Plant).
  • ODM/OEM Health Supplement Manufacturing (專業代工ODM/OEM) Original design and manufacturing services for health supplements, offering exclusive patented raw materials (BRAP-01, BR-022, BR-0121, Cordyceps, Antrodia), full dosage form production including patented micro-pellet formulations, and packaging design for brand partners.

Quantifiable outcome

  • Over 500 stage IV solid tumor patients treated with CIK cell therapy
  • +8 more outcomes

Companies that use BioRay Biotech

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

BioRay Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

BioRay Biotech partnerships and signals

Strategic signal

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

BioRay Biotech competitors and assessment

Company assessment

Broad incumbents

  • Probi AB: Swedish global leader in probiotic R&D and B2B ingredient licensing with clinically documented Lactobacillus strains. Comparable as a probiotic IP licensor selling patented strains into supplement and functional food brands worldwide.
  • Lonza Group: Global contract development and manufacturing organization (CDMO) for biologics and cell & gene therapies. Comparable as a provider of GMP/GTP-equivalent cell therapy manufacturing services, though at much larger scale.
  • Yakult Honsha: Global probiotic dairy and supplement brand built on proprietary Lactobacillus strain science (Shirota strain). Comparable as a vertically integrated probiotic IP owner with branded consumer products and B2B licensing.
  • Chr. Hansen (now Novonesis): Global bioscience major with one of the world's largest commercial probiotic strain libraries and B2B ingredient supply across food, supplement, and animal health. Comparable as a scale probiotic raw-material and culture supplier competing for the same brand customers.
  • Kerry Group: Global taste and nutrition company with a major probiotic and postbiotic ingredient business serving supplement, dairy, and functional food brands. Comparable as a large-scale buyer of probiotic technology and competitor for branded health-supplement customers.

Direct peers

  • SunWay Biotech: Taiwan-based biotech active in immune cell therapies (including CIK/DC-CIK) and precision testing. Closely comparable to BioRay's CIK cell therapy and precision testing service lines.
  • GenMont Biotech: Taiwan-based probiotic and functional ingredient manufacturer with patented Lactobacillus strains and ODM/OEM services. Highly comparable to BioRay's supplement franchise, including strain bank ownership and international B2B raw material exports.
  • TCI Bio: Taiwan nutraceutical/functional food contract manufacturer with ODM/OEM capabilities and proprietary ingredient IP. Comparable as a Taiwanese health-supplement ODM competitor with patented raw materials.
  • Grape King Bio: Taiwan-listed health supplement and probiotic company combining proprietary fermentation with branded products and OEM services. Closely comparable in business model (probiotics + health foods + ODM) and target customer base.

Regional players

  • PharmaEssentia: Taiwan-listed biopharmaceutical company developing biologic drugs (notably ropeginterferon). Comparable as a Taiwan biotech pursuing international commercialization of a proprietary biologic, though focused on oncology/inflammation rather than probiotics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

BioRay Biotech compliance and trust

Trust signal

Compliance7 records

BioRay Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioRay Biotech leadership team

Management profile

Number of profiles

Profiles8 records

BioRay Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioRay Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioRay Biotech

What does BioRay Biotech do?

BioRay Biotech researches, develops, manufactures, and distributes bio-pharmaceutical products spanning three integrated business lines: (1) precision medical testing services including cancer risk assessment, immune function analysis, gut microbiome analysis, and holistic health data insights built on six integrated technology platforms; (2) CIK (Cytokine-Induced Killer) immune cell therapy services delivered through GTP-certified facilities and partner hospitals for solid tumor patients; and (3) branded and ODM/OEM health supplement products based on 17 patented probiotic strains, Cordyceps militaris, Antrodia cinnamomea, and patented micro-pellet formulation technology.

Is BioRay Biotech a public or private company?

BioRay Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BioRay Biotech founded?

BioRay Biotech was founded in 2000. It employs 11 to 50 people.

Where is BioRay Biotech based?

BioRay Biotech is headquartered in Pingtung, Taiwan, in the Asia region.

How does BioRay Biotech make money?

Five revenue lines are on record. Health Supplement Sales (Own Brands) is the primary driver. The others are ODM/OEM Contract Manufacturing, CIK Immune Cell Therapy, precision Medical Testing Services and patented Raw Material Licensing.

Who are BioRay Biotech's main competitors?

Broad incumbents on record are Probi AB, Lonza Group, Yakult Honsha, Chr. Hansen (now Novonesis) and Kerry Group. Direct peers are SunWay Biotech, GenMont Biotech, TCI Bio and Grape King Bio. PharmaEssentia is listed as a regional player.

Does BioRay Biotech have an API?

No public API is recorded for BioRay Biotech.

What industry is BioRay Biotech in?

BioRay Biotech's product category is Bio-pharmaceutical Probiotics and Cell Therapy. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of HLAIAAAD, Immunology & Inflammation Pharmaceuticals. Its NAICS code is 325414 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales